Lzi Multiple Analyte Set A;B;C Drugs of Abuse Controls

FDA 510(k) K133710 · Lin-Zhi International, Inc.

Substantially Equivalent

510(k) numberK133710

Submission

Device name
Lzi Multiple Analyte Set A;B;C Drugs of Abuse Controls
Applicant
Lin-Zhi International, Inc.
Sunnyvale, CA, US
Received
December 4, 2013
Decision date
February 21, 2014
Decision
Substantially Equivalent (SESE)
Type
Traditional 510(k)
Summary
510(k) summary available from FDA

Official FDA 510(k) record

Device classification

Product code
DKB – Calibrators, Drug Mixture
Device class
Class II (moderate risk)
Regulation
21 CFR 862.3200
Specialty
Clinical Toxicology

Other 510(k)s with product code DKB

510(k)DeviceApplicantDecision
K141928Cobas C Acetaminophen GEN.2 Assay, ACET2 CalibratorDKB · Traditional Roche Diagnostics Operations (Rdo)11/25/2014SE
K120936Abbott TDM Multiconstituent Calibrator, Thermo Scientific QMS Multi-Constituent…DKB · Abbreviated Microgenics Corporation12/13/2012SE
K092266Randox Methamphetamine AssayDKB · Traditional Randox Laboratories, Ltd.05/09/2011SE
K101752Thermo Scientific Cedia Multi-Drug Oft CalibratorsDKB · Traditional Microgenics Corp.04/08/2011SE
K090939Roche C.F.A.S. Dat Qualitative Plus Clinical Calibrator and Control Set Dat Clinical…DKB · Traditional Roche Diagnostics06/18/2009SE
K090900Advia Chemistry Drug Calibrator II, Model 10376771DKB · Abbreviated Siemens Healthcare Diagnostics06/01/2009SE
K062162Dimension Vista System Drugs of Abuse Calibrator (Udat Cal - KC510)DKB · Traditional Dade Behring, Inc.09/14/2006SE
K062121Dimension Vista System Drug 2 Calibrator (Drug 2 Cal - KC420)DKB · Traditional Dade Behring, Inc.08/25/2006SE
K060645Preciset Dat Plus I, Preciset Dat Plus II and Cfas Dat Qualitative Plus CalibratorsDKB · Abbreviated Roche Diagnostics Corp.05/30/2006SE
K051088Multiple Analyte Urine Drugs of Abuse Calibrators and ControlsDKB · Traditional Lin-Zhi International, Inc.06/24/2005SE

More from Lin-Zhi International, Inc.

510(k)DeviceDecision
K253082LZI Buprenorphine II Enzyme ImmunoassayDJG · Traditional 01/16/2026SE
K251634LZI Fentanyl III Enzyme ImmunoassayDJG · Special 06/18/2025SE
K202007LZI Oxycodone III Enzyme ImmunoassayDJG · Traditional 09/17/2020SE
K201938LZI Fentanyl II Enzyme ImmunoassayDJG · Traditional 08/07/2020SE
K201223LZI Tramadol Enzyme ImmunoassayDJG · Traditional 06/04/2020SE
K192299LZI Cotinine II Enzyme ImmunoassayMKU · Traditional 11/21/2019SE
K192433LZI Methadone II Enzyme ImmunoassayDJR · Traditional 10/04/2019SE
K181159LZI Fentanyl Enzyme ImmunoassayDJG · Traditional 12/03/2018SE
K170416LZI Methadone Metabolite Enzyme Immunoassay, LZI Methadone Metabolite (100 and 300)…DJR · Traditional 06/26/2017SE
K141320LZI Oral Fluid Cannabinoids Enzyme Immunoassay, LZI Oral Fluid Cannabinoids Calibrators…LDJ · Traditional 05/28/2015SE

Questions and answers

When was Lzi Multiple Analyte Set A;B;C Drugs of Abuse Controls cleared by the FDA?

Lzi Multiple Analyte Set A;B;C Drugs of Abuse Controls (K133710) received a 510(k) decision of Substantially Equivalent on February 21, 2014, 79 days after the submission was received.

What is the product code of K133710?

The FDA product code is DKB – Calibrators, Drug Mixture, a Class II (moderate risk) device regulated under 21 CFR 862.3200.